Anti-Jo-1

Alphabetical Test listing

Anti-Jo-1-13408

  
Anti-Jo-1
  
13408
  
LAB13408
  
JO1
  
Polymyositis
t-RNA synthetase
  

Evaluate patients suspected of having polymyositis, dermatomyositis, or polymyositis-scleroderma overlap syndrome.

Anti-Jo-1 antibodies are present in approximately 20% to 30% of patients with adult-onset polymyositis syndromes. They are present in >65% of patients with both myositis and interstitial lung disease. In such patients, the presence of anti-Jo-1 antibodies may be predictive of a response to steroid treatment. Testing for ANAs is not adequate for the detection of anti-Jo-1 antibodies.

  
Serum
  
  
0.6 mL
  
0.3 mL
  

Immediatley following collection, mix sample by gently inverting 5 times

  
  1. Allow sample to clot for a minimum of 30 minutes
  2. Spin within two (2) hours of sample collection
  

Gold serum separator (SST) tube

  
  
  1. Allow sample to clot
  2. Spin 
  3. Transfer serum to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as serum, within two (2) hours of sample collection
  
  

Ambient (preferred) - 14 days

Refrigerated - 14 days

Frozen - 14 days

Freeze/thaw cycles - stable x 3

  
  • Hemolysis
  • Icterus
  • Lipemia
  • Bacterial contamination
  
LabCorp Burlington (161455): R-LC
  
Mo - Sa
  
1 - 3 days
  

Multiplex flow immunoassay

  

0.0 - 0.9 AI

  
86235
  
Result 11565-9
  
03/27/2019
  
03/29/2021
  
02/12/2021